Exploration of the amino acid metabolic signature in anthracycline-induced cardiotoxicity using an optimized targeted metabolomics approach based on UPLC-MS/MS-Reference-Cited by-同舟云学术

Exploration of the amino acid metabolic signature in anthracycline-induced cardiotoxicity using an optimized targeted metabolomics approach based on UPLC-MS/MS

Published:2022-07-26 Issue:10 Volume:395 Page:1209-1224
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmiedeberg's Arch Pharmacol

Author:

Li Wendi,Li Shanshan,Cao Zhenju,Sun Yi,Qiu Wei,Jia Mei,Su Ming^ORCID

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00210-022-02271-x.pdf

Reference53 articles.

1. Arai M, Yoguchi A, Takizawa T, Yokoyama T, Kanda T, Kurabayashi M, Nagai R (2000) Mechanism of doxorubicin-induced inhibition of sarcoplasmic reticulum Ca(2+)-ATPase gene transcription. Circ Res 86:8–14. https://doi.org/10.1161/01.res.86.1.8

2. Asnani A, Shi X, Farrell L, Lall R, Sebag I, Plana J, Gerszten R, Scherrer-Crosbie M (2020) Changes in citric acid cycle and nucleoside metabolism are associated with anthracycline cardiotoxicity in patients with breast cancer. J Cardiovasc Transl Res 13:349–356. https://doi.org/10.1007/s12265-019-09897-y

3. Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni C, Veglia F, Civelli M, Lamantia G, Colombo N, Curigliano G, Fiorentini C, Cipolla C (2015) Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation 131:1981–1988. https://doi.org/10.1161/circulationaha.114.013777

4. Cheng C, Liu M, Tang H, Cheng M, Wang C (2021) Factors associated with elevated plasma phenylalanine in patients with heart failure. Amino Acids 53:149–157. https://doi.org/10.1007/s00726-020-02933-1

5. De Jong K, Lopaschuk G (2017) Complex energy metabolic changes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction. Can J Cardiol 33:860–871. https://doi.org/10.1016/j.cjca.2017.03.009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods;Current Treatment Options in Oncology;2024-04-27

2. Integrative Analysis of Toxicometabolomics and Toxicoproteomics Data: New Molecular Insights into Thiazolidinedione-Induced Cardiotoxicity;2024-03-05